Urogen Pharma Ltd (URGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | URGN | SRPT | HCM | ||
| Company | Urogen Pharma Ltd | Sarepta Therapeutics | Hutchmed China Ltd ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 45.09 | 21.49 | 12.40 | ||
| High | 45.53 | 22.58 | 12.48 | ||
| Low | 43.39 | 20.83 | 12.34 | ||
| Last | 43.62 | 20.86 | 12.38 | ||
| Change | -1.88 | -0.73 | -0.03 | ||
| Percent Change | -4.13% | -3.38% | -0.28% | ||
| Volume | 580,048 | 3,612,224 | 59,140 | ||
| 20-Day Average Volume | 1,020,507 | 3,006,096 | 62,882 | ||
| Previous | 45.50 | 21.59 | 12.41 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 46.29 | 18.25 | 12.26 | ||
| 20-Day Raw Stochastic | 49.12% | 77.93% | 68.00% | ||
| 20-Day Relative Strength | 51.41 | 62.47 | 56.72 | ||
| Weighted Alpha | +127.52 | +21.94 | -17.30 | ||
| Today's Opinion | 88% Buy | 8% Buy | 8% Sell | ||
| Yesterday's Opinion | 88% Buy | 8% Buy | 8% Sell | ||
| Last Month's Opinion | 100% Buy | 88% Sell | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.91% since 08/21/26 | +11.02% since 08/21/26 | -1.98% since 08/21/26 | ||
| Low | 43.39 on 08/28/26 | 17.90 on 08/24/26 | 12.09 on 08/24/26 | ||
| High | 47.17 on 08/25/26 | 22.59 on 08/27/26 | 12.58 on 08/24/26 | ||
| 1-Month | |||||
| %Chg | +6.70% since 07/28/26 | +35.19% since 07/28/26 | +10.54% since 07/28/26 | ||
| Low | 36.68 on 08/03/26 | 14.75 on 08/03/26 | 10.62 on 07/30/26 | ||
| High | 50.81 on 08/19/26 | 22.59 on 08/27/26 | 12.90 on 08/17/26 | ||
| 3-Month | |||||
| %Chg | +52.04% since 05/28/26 | +20.58% since 05/28/26 | +10.24% since 05/28/26 | ||
| Low | 26.00 on 06/01/26 | 14.68 on 06/11/26 | 9.77 on 06/22/26 | ||
| High | 50.81 on 08/19/26 | 22.59 on 08/27/26 | 12.90 on 08/17/26 | ||
| 6-Month | |||||
| %Chg | +101.01% since 02/27/26 | +24.46% since 02/27/26 | -13.61% since 02/27/26 | ||
| Low | 16.50 on 03/30/26 | 14.68 on 06/11/26 | 9.77 on 06/22/26 | ||
| High | 50.81 on 08/19/26 | 23.85 on 03/25/26 | 15.79 on 04/17/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,224,086 | 2,280,487 | 2,166,008 | ||
| Shares Outstanding, K | 48,881 | 105,627 | 174,467 | ||
| Annual Sales, $M | 109,790,000 | 2,198,240,000 | 548,510,000 | ||
| Annual Net Income, $M | -153,490,000 | -713,410,000 | 456,910,000 | ||
| Last Qtr Sales, $M | 72,460,000 | 401,250,000 | 75,806,000 | ||
| Last Qtr Income, $M | -14,350,000 | -4,890,000 | -61,254,000 | ||
| 60-Month Beta | 1.57 | 0.23 | 0.23 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.28 on 08/05/26 | 0.64 on 08/05/26 | N/A on 07/28/21 | ||
| Latest Earnings Date | 11/05/26 | 11/02/26 | 07/30/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||